Similarly, pharmacologic inhibition of STAT3 or genetic depletion of CCL2 and CCL7 reduced pro-tumor CD45highCD11b+CD68+CD206+ macrophages in CT2A tumors (Supplementary Fig. S15l–o). The gene discussed is CCL7; the disease is neoplasm.